Eli Lilly acquires Sigilon to bolster its diabetes prospects

The latest stories trending on MedCity News.

Editor's Pick

Top Story Eli Lilly to Buy Sigilon, Betting the Biotech Can Overcome a Cell Therapy Limitation Eli Lilly is expanding its diabetes prospects by acquiring cell therapy developer Sigilon Therapeutics. The two companies are already partners in the development of a type 1 diabetes cell therapy currently in preclinical development. Sponsored Content The Right Balance of Conversational AI and Human Support Makes the Most Impact on Health System Patients, Staff and Business Presented by MedCity News & Parlance On the surface, it sounds like one of the simplest procedures undertaken at a health system: answering the phone. But anyone who works at a health system knows it is not that simple. Learn More>>

Featured News

FDA Approves BioMarin Pharma's Gene Therapy, the First for Hemophilia A The FDA approved Roctavian for treating hemophilia A. The regulatory decision makes the BioMarin Pharmaceutical product the first gene therapy for this inherited bleeding disorder. How Telemedicine Can Combat Clinician Burnout, the Biggest Challenge Facing the Healthcare Industry To fully reap the benefits of telemedicine, it is crucial to provide comprehensive education to both staff and patients. Clinicians, doctors, and other medical care providers should all be trained on telehealth software — its functionality, integration into their workflow, effective communication during consultations, and where to seek technical assistance. New Israeli Health Tech Fund Launches to Invest in Pre-Seed and Seed-Stage Startups Israeli health tech fund Shoni Health Ventures recently launched to invest in digital health and medical device startups that are in the pre-seed and seed stages of fundraising. The fund is affiliated with Sheba Medical Center, the largest hospital in Israel. Startups will have access to the hospital's innovation center so that they can develop, pilot and commercialize their products. Highmark Blue Cross Blue Shield Delaware Taps Wellinks for Virtual COPD Care Starting July 1, Highmark Blue Cross Blue Shield Delaware members will be able to access Wellinks' virtual services for Chronic Obstructive Pulmonary Disease (COPD). These services include pulmonary rehabilitation, coaching and tracking through connected devices and an app. UNC Health Pilots In-House Generative AI App to Alleviate Burnout UNC Health recently launched a pilot for its in-house generative AI app called Ava, which stands for "AI virtual assistant." The app allows staff members to ask questions about the different digital health tools available to them across the health system, and it gives them concise answers about how to use the tools effectively. The goal is to prevent staff from searching through vast training libraries.

Resources

MedCity Pivot Podcast: 2 Perspectives on how AI Can Soothe Burnout, Burden of Prior Authorization Presented by MedCity News In this interview with Punit Singh Soni, CEO of Suki and Niall O'Connor, CTO, Cohere Health, they evaluate two areas where AI can have an outsize impact: clinical documentation and prior authorization. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe